Phase I study of NGR-hTNF, a selective vascular targeting agent, in combination with cisplatin in refractory solid tumors (Q34163587)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study of NGR-hTNF, a selective vascular targeting agent, in combination with cisplatin in refractory solid tumors |
scientific article |
Statements
1 reference
Phase I study of NGR-hTNF, a selective vascular targeting agent, in combination with cisplatin in refractory solid tumors (English)
1 reference
Claudio Bordignon
1 reference
Vanesa Gregorc
1 reference
Filippo G De Braud
1 reference
Tommaso M De Pas
1 reference
Roberto Scalamogna
1 reference
Giovanni Citterio
1 reference
Alessandra Milani
1 reference
Sabrina Boselli
1 reference
Chiara Catania
1 reference
Giovanni Donadoni
1 reference
Gilda Rossoni
1 reference
Domenico Ghio
1 reference
Gianluca Spitaleri
1 reference
Cristina Ammannati
1 reference
Scialini Colombi
1 reference
Federico Caligaris-Cappio
1 reference
Antonio Lambiase
1 reference
9 February 2011
1 reference
1 reference
Identifiers
1 reference